GlobalData on MSN

BD secures FDA 510(k) clearance for EnCor EnCompass system

BD expects to bring the system to market in early 2026.

BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System

BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.

BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S.
MassDevice

BD wins FDA nod for breast biopsy, tissue removal system

BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...
Business Wire

New 3M 360 Encompass System – Professional Promotes Accurate and Compliant Professional Fee Coding

SALT LAKE CITY--(BUSINESS WIRE)--3M Health Information Systems is expanding its market-leading 3M 360 Encompass System platform to introduce 3M 360 Encompass System – Professional, the industry’s ...
Fierce Healthcare

U.S. Hospitals Prepare for ICD-10 Implementation with 3M 360 Encompass System

SALT LAKE CITY--(BUSINESS WIRE)-- Healthcare reform, new compliance regulations, and the move to outcomes-based payment are putting pressure on clinical documentation and coding processes at hospitals ...
Business Wire

TransPerfect’s Updated EnCompass System Transforms Regulatory Compliance Into Competitive Advantage for Medical Device Manufacturers

BOSTON--(BUSINESS WIRE)--TransPerfect Medical Device Solutions and 121nexus today announced an update to the EnCompass system for content automation and distribution. The updated system is designed to ...
Business Insider

3M Acclaimed by Frost & Sullivan for the 3M™ 360 Encompass™ System, Its AI-driven Technology for Healthcare Coding and Documentation

The 3M™ 360 Encompass™ System seamlessly integrates CAC, CDI, concurrent quality metrics, and analytics to capture, analyze, and advance patient information across the continuum of care SANTA CLARA, ...

BD (Becton, Dickinson and Company): BD Receives FDA 510(k) Clearance for EnCor EnCompass Breast Biopsy and Tissue Removal System

State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026 FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: ...